Background
==========

Mesenchymal stromal/stem cells (MSCs) are a group of multipotent stromal cells with capacity of self-renewal and multilineage potential that can differentiate into osteoblasts, chondrocyte, myocytes, and adipocytes \[[@b1-medscimonit-24-264]--[@b3-medscimonit-24-264]\]. MSCs has been broadly used and proven safe and effective in clinical cell therapy trials for many diseases, such as stroke, neurodegenerative diseases, myocardial infarction, diabetes, and kidney injury \[[@b4-medscimonit-24-264]--[@b7-medscimonit-24-264]\]. There are also reports of adverse effect of MSC in clinical studies \[[@b8-medscimonit-24-264]\] and in clinical trials \[[@b9-medscimonit-24-264]\], suggesting MSCs must be used with extreme caution in clinical experiments and in clinical trials \[[@b8-medscimonit-24-264],[@b10-medscimonit-24-264]\]. However, it is well accepted that the therapeutic outcomes of MSCs are attributed to direct cell differentiation and paracrine effects that promote endogenous tissue regeneration, anti-inflammation, and anti-apoptosis \[[@b11-medscimonit-24-264]\]. Although MSCs therapies have shown promising effectiveness, the efficacy of MSC transplantation is far from satisfactory due to low viability and high cell death rate of transplanted MSCs \[[@b12-medscimonit-24-264]--[@b14-medscimonit-24-264]\].

A highly stressful microenvironment is the main factor that induces apoptosis in engrafted MSCs \[[@b15-medscimonit-24-264],[@b16-medscimonit-24-264]\]. In ischemia tissue (e.g., cardiac muscle or brain infarction), increased reactive oxygen species (ROS) induces massive cell death of donor MSCs and thus shortens its effective time to only a few days \[[@b6-medscimonit-24-264]\]. Prevention of MSC apoptosis from ROS challenge is urgently needed for improving the therapeutic outcome of MSCs therapy.

MicroRNAs (miRNAs) are small non-coding RNAs (approximately 22 nucleotides in length) which play vital roles in post-transcriptional regulation of gene expression. miRNAs can base-pair with complementary sequences with target mRNAs and silence the protein translation process by cleavage or destabilization of target mRNA and stop protein translation. Among the various miRNAs, miR-34a is a direct transcriptional target of p53 \[[@b17-medscimonit-24-264],[@b18-medscimonit-24-264]\], which is considered as the gatekeeper protein that determinates if a cell should undergo cell-cycle arrest, repair, or apoptosis under ROS and oxidative stress \[[@b19-medscimonit-24-264],[@b20-medscimonit-24-264]\]. The p53 pathway is involved in MSC apoptosis, and platelet-derived growth factor treatment decreased the expression of p53 and protected MSCs from apoptosis under hypoxia condition \[[@b21-medscimonit-24-264],[@b22-medscimonit-24-264]\]. p53 activation induces expression of miR-34a both *in vivo* and *in vitro*. In unrelated cell lines, such as cancer cell lines, inactivation of miR-34a strongly inhibits p53-mediated apoptosis in a cell stress condition, while overexpression of miR-34a increases apoptosis and cell-cycle arrest \[[@b23-medscimonit-24-264]\]. In our previous work, we demonstrated that miR-34a is involved in stem cell fate determination and regeneration in the nervous system \[[@b5-medscimonit-24-264]\]. We also found that miR-34a expression was negatively correlated with cell survival rate in rat bone marrow-derived dedifferentiated MSCs \[[@b5-medscimonit-24-264]\]. Emerging evidence indicates that miRNAs are actively involved in MSC differentiation \[[@b5-medscimonit-24-264],[@b24-medscimonit-24-264]\], but there has been scant study of the role of miR-34a in the apoptosis of MSCs under stressful conditions.

In the present study, we sought to determine if miR-34a is involved in apoptosis of human bone marrow MSCs under oxidative stress induced by H~2~O~2~ and to provide a new target to improve MSC survival in cell therapies in multiple diseases.

Material and Methods
====================

Cell culture
------------

Human bone marrow MSCs were purchased from Lonza (Walkersville, MD, USA). These cells have been tested for MSC surface marker expression and multilineage differentiation ability. Briefly, cells were cultured in alpha-MEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen) at 37°C in a humidified 5% CO~2~ incubator, and media were changed every 2--3 days. After reaching to 70--80% confluence, cells were washed with phosphate-buffered saline (PBS), detached with 0.25% trypsin-EDTA (Invitrogen), then centrifuged and expanded at 1: 3 split ratios.

Transfection of miR-34a inhibitor (anti-34a)
--------------------------------------------

MSCs were transfected with anti-34a as previously described \[[@b5-medscimonit-24-264],[@b4-medscimonit-24-264]\]. Briefly, MSCs were seeded at a density of 2×10^5^ cells per well in 6-well plates in culture medium without antibiotics. Cells were transfected with 200 nM anti-34a and negative control (Ambion, USA) using Lipofectamine 2000 (Invitrogen) at 70% confluence following the manufacturer's instructions. Transfection efficiency was determined by quantitative real-time PCR at day 1 and day 2 after transfection.

Detection of miR-34a expression
-------------------------------

Total RNA was extracted using the mirVana miRNA isolation kit (Applied Biosystems/Ambion, Austin, TX) according to the manufacturer's instructions. We converted 40 ng total RNA to cDNA using a TaqMan microRNA Reverse Transcription kit (Applied Biosystems) with specific primers for miR-34a and RNU48. Real-time PCR was carried out on the ABI 7500 real-time PCR machine (Applied Biosystems) in reaction volumes of 20 μl containing 10 μl TaqMan 2× Universal PCR Master Mix, no AmpErase UNG, 1 μl 20× TaqMan microRNA Assay Mix (Applied Biosystems) and 1.33 μl template cDNA. Thermal cycling conditions were 40 cycles at 95°C for 15 s and 60°C for 60 s. RNU48 was used as an endogenous control. Relative expression of miR-34a was calculated using the comparative delta-delta Ct value method.

Cell proliferation assay
------------------------

Cell proliferation was determined using Cell Titer96^®^ Aqueous cell proliferation assay (Promega, Madison, WI). Briefly, MSCs were seeded in triplicates in 96-well plates at a density of 1×10^3^ cells/well in 100 μl full culture medium and transfected with anti-34a, as described above. One day post-transfection, cells were treated with 100 μM H~2~O~2~ for 1 h. Cells were incubated with 20 μl Cell Titer96 Aqueous One solution 24 h later, according to the manufacturer's protocol. Viable cells were spectrophotometrically measured at a wavelength of 490 nm.

SYBR Green-based real-time PCR for other target genes
-----------------------------------------------------

SYBR Green-based real-time PCR was employed to measure relative mRNA expression levels of Bcl-2, Survivin, and Ki-67. Total mRNA was extracted using Trizol (Invitrogen) according to the manufacturer's instructions and then quantified using a Nano-drop ND-2000 spectrophotometer. We reverse-transcribed 500 ng mRNA using the High-Capacity cDNA synthesis kit (Applied Biosystems). All qPCR was performed in triplicate using the SYBR Green PCR Master Mix kit (Life Technologies) on an ABI 7500 real-time PCR machine (Applied Biosystems) starting at a hold stage of 95°C for 10 min, and 40 cycles of denaturation at 95°C for 15 s, annealing/extension at 60°C for 60 s followed by disassociation melt curve analysis. Negative controls (no template) were also conducted in triplicate for all target genes. Beta-actin expression was used as an internal control. Relative mRNA levels were expressed as fold-change compared to untreated cells.

Western blot analysis
---------------------

Cells were lysed in RIPA buffer (150 mM NaCl; 50 mM Tris-Cl, pH 8.0; 1% NP-40; 0.5%; DOC; 0.1% SDS), and total protein extracts were collected. Protein concentration was determined using bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL) and 30 μg of total protein was loaded into 10% SDS-PAGE gel. Following electrophoresis, proteins were transferred onto the nitrocellulose membranes (Millipore, USA). The membranes were blocked for non-specific binding with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween 20 (TBST) for 1 h at room temperature and then incubated with specific primary antibodies at 4°C overnight. After washing 3 times with TBST, membranes were incubated with HRP-conjugated secondary antibodies (Cell Signaling Technology, 1: 10 000) for 1 h at room temperature. Later, the signals were detected by chemiluminescence using ECL kit (Pierce, USA). Primary antibodies used in this study were: anti-Bcl-2 (Santa Cruz, 1: 200), anti-Survivin (Cell Signaling Technology, 1: 500), and anti-beta-Actin (Sigma, 1: 2000).

Immunostaining
--------------

Cells were cultured on chamber slides and treated with H~2~O~2~ (0, 50,100, 200, and 500 μM) for 1 h. Then, 24 h later, cells were fixed with 4% paraformaldehyde in PBS, blocked in 5% normal serum at room temperature for 1 h, followed with primary antibody for Ki67 (Cell Signaling Technology) at 4°C overnight. Then, cells were washed with PBS and incubated with secondary antibodies (Alexa Fluor568 goat anti-rabbit IgG, Invitrogen). Samples were counterstained with DAPI (49,6-diamidino-2-phenylindole; Invitrogen), examined with an Olympus Eclipse 80i Upright Microscope, and photographed using a SPOT RT-SE6 1.4MP Slider camera system (Diagnostic Instruments, Inc.).

Statistical analysis
--------------------

The data were processed using Prism 5.0 software. Data are reported as means ±SEM if not indicated otherwise. Comparisons among values for all groups were performed by one-way ANOVA or Student's t-test. A "P" value of less than 0.05 was considered statistically significant.

Results
=======

H~2~O~2~ challenge increased miR-34a levels in MSCs
---------------------------------------------------

To determine whether oxidative stress can change miR-34a level in MSCs, we used 100 μM H~2~O~2~ to treat the cells for 1 h in normal culture conditions. Mild ROS is provided by 100 μM H~2~O~2~ and can directly produce free radicals, including hydroxyl radical, which induces DNA injury and membrane lipid peroxidation \[[@b14-medscimonit-24-264],[@b25-medscimonit-24-264]\]. After 1 h of H~2~O~2~ treatment, the expression level of miR-34a was dramatically increased compared to the control group, indicating that 100 μM H~2~O~2~ stimulation activates miR-34a expression in MSCs ([Figure 1](#f1-medscimonit-24-264){ref-type="fig"}).

Anti-34a successfully reduced miR-34a level by 70% in MSCs
----------------------------------------------------------

To determine if miR-34a can be down-regulated by anti-34a, 200 nM anti-34a were transfected into MSCs by using Lipofectamine 2000. After 24 h of transfection, the miR-34a level was significantly down-regulated by about 70% ([Figure 2](#f2-medscimonit-24-264){ref-type="fig"}). This result indicates that the level of miR-34a in MSCs can be manipulated using anti-34a.

Anti-34a rescued H~2~O~2~ -induced cell death in MSCs
-----------------------------------------------------

We next performed cell proliferation assay to determine if H~2~O~2~-induced cell death of MSCs is mediated by miR-34a. First, we did a pre-test to verify that the effects of anti-34a still existed after 2 days of transfection followed by H~2~O~2~ exposure. Anti-34a reduced miR-34a level by 50% at 48 h after transfection ([Figure 3A](#f3-medscimonit-24-264){ref-type="fig"}). One day post-transfection, cells were treated with 100 μM H~2~O~2~ or vehicle for 1 h, and the number of viable cells was measured 24 h later. As shown in [Figure 3B](#f3-medscimonit-24-264){ref-type="fig"}, H~2~O~2~ treatment significantly decreased the number of living cells by 50--60% compared with the control group. MSCs pre-transfected with anti-34a exhibited a markedly higher number of viable cells under H~2~O~2~ stress, indicating inhibition of miR-34a in MSCs enhanced cell survival against H~2~O~2~ stress.

Anti-34a rescued Bcl-2, Survivin, and Ki67 levels reduced by H~2~O~2~ exposure
------------------------------------------------------------------------------

To explore the underlying mechanism of the effect of anti-34a against oxidative stress induced by H~2~O~2~, we hypothesized that anti-34a modulates the balance between cell proliferation and cell death. It has been reported that H~2~O~2~ represses anti-apoptotic gene Bcl-2 expression in many cell lines \[[@b15-medscimonit-24-264],[@b26-medscimonit-24-264]\]. Hence, we measured the mRNA levels of Bcl-2 and a proliferation marker Ki67 to see whether anti34a could rescue the down-regulation of Bcl-2 and Ki67 induced by H~2~O~2~ treatment. As shown in [Figure 4A](#f4-medscimonit-24-264){ref-type="fig"}, H~2~O~2~ significantly reduced mRNA expression of Bcl-2 in MSCs. Anti-34a not only rescued Bcl-2 mRNA decrease, but, more interestingly, augmented Bcl-2 mRNA to a level even higher than that of the normal control group. The protein expression level of Bcl-2 was totally eliminated in H~2~O~2~ treatment groups, whereas anti-34a could also partially restore Bcl-2 protein from H~2~O~2~ stress ([Figure 4B](#f4-medscimonit-24-264){ref-type="fig"}). Likewise, Survivin, another important survival-related protein, showed a similar expression trend. The proliferation marker Ki67 was also dramatically increased in the anti-34a group ([Figure 4A](#f4-medscimonit-24-264){ref-type="fig"}, [Supplementary Figure 1](#s1-medscimonit-24-264){ref-type="supplementary-material"}), which suggested that inhibition of miR-34a promotes cell proliferation. These results demonstrated that enhanced expression of Bcl-2, Survivin, and Ki67 contributed to the protective effect of anti-34a in MSCs.

Discussion
==========

MSCs have been extensively used in clinical trials as stem cell therapy for a wide range of diseases in the past 10 years due to their clinical safety, multipotency, low immunogenicity, immunosuppressive properties, and production of cytokines and growth factors \[[@b11-medscimonit-24-264],[@b27-medscimonit-24-264],[@b28-medscimonit-24-264]\]. MSC based cell therapy has been proven effective in many diseases, including neurodegenerative disease \[[@b4-medscimonit-24-264]\], stroke \[[@b29-medscimonit-24-264]\], heart disease \[[@b7-medscimonit-24-264]\], and kidney injury \[[@b30-medscimonit-24-264]\]. Although significant progress has been made in MSC therapy, there are still several major hurdles limiting its widespread use. Low viability of transplanted MSCs is one of the major obstacles. ROS might play a crucial role in limiting the survival of engrafted MSCs. Increased ROS by ischemia induces neuronal or myocardial necrosis and infarction. Moreover, high levels of ROS in the ischemic tissue (i.e., brain or myocardium) are also harmful to the engrafted MSCs \[[@b31-medscimonit-24-264],[@b32-medscimonit-24-264]\]. ROS accumulation is an important effector that activates the p53 pathway, which in turn induces cell apoptosis \[[@b19-medscimonit-24-264]\]. ROS inhibitor ameliorates senescence or apoptosis in cancer cells and stem cells \[[@b33-medscimonit-24-264]--[@b35-medscimonit-24-264]\]. These findings suggest that ROS is a priming effector that induces cell apoptosis, especially in ischemic tissue where ROS is highly elevated due to massive death cell. Therefore, the engrafted MSCs in the ischemic area thus might sustain oxidative stress from high levels of ROS in the microenvironment, resulting in MSC apoptosis and limitation of their therapeutic effect. Enhancing the survival of engrafted MSCs has been an attractive strategy to improve MSC therapeutic outcomes in the past few years. Several *ex vivo* genetic modification of MSCs targeting Bcl-2, TLR4, Survivin, and CCR1/CXCR2 has been proposed and proven effective in enhancing MSC survival \[[@b36-medscimonit-24-264]\]. Li et al. found that overexpression of Bcl-2 in MSCs reduced MSC apoptosis by 32% *in vitro*, and surviving MSCs were about 1--2 fold higher than that of control MSCs at different time points after cell transplantation in a rat myocardial infarction model \[[@b13-medscimonit-24-264]\]. We found that MSCs that have undergone a dedifferentiation-reprogramming improved cell survival in an H~2~O~2~ oxidative stress model and an *in vivo* rat hypoxia-ischemic brain damage model, and these improvements were partly attributed to increased Bcl-2 expression and decreased miR-34a in the dedifferentiation-reprogrammed MSCs \[[@b5-medscimonit-24-264]\].

Interestingly, a recent study showed hypoxia induced regulation of miR-34a in colorectal cancer cells, providing evidence of the link between miR-34 and ROS \[[@b37-medscimonit-24-264]\]. In the present study, we first confirmed that the miR-34a level in MSCs was significantly increased under mild H~2~O~2~-mediated oxidative stress. Anti-34a successfully repressed miR-34a expression in MSCs under control conditions. These data indicate that miR-34a is constantly expressed in MSCs, consistent with another report that miR-34a is functionally expressed in mouse neural stem cells \[[@b24-medscimonit-24-264]\]. H~2~O~2~ induced massive MSCs cell death, and pre-transfection of anti-34a could partially rescue cell death induced by H~2~O~2~. Bcl-2 is a 26-kDa anti-apoptotic protein serving as a critical regulator of the apoptotic pathway to inhibit cell death \[[@b38-medscimonit-24-264]\]. Several lines of evidence indicate that miR-34a directly targets Bcl-2 mRNA and represses its expression \[[@b39-medscimonit-24-264]\]. Consistent with previous findings, we found that H~2~O~2~ treatment severely reduced Bcl-2 mRNA and protein levels in MSCs. Pre-transfection of anti-34a into MSCs dramatically increased Bcl-2 mRNA level and partially restored its protein level. The proliferation marker Ki67 showed a similar trend as that of Bcl-2. Most interestingly, anti-34a treatment not only restored the mRNA level of Bcl-2 and Ki67, but achieved even higher levels than that of the control group. This finding indicates that miR-34a is constantly expressed in MSCs and is functionally involved in the regulation of cell proliferation and cell death.

Conclusions
===========

In summary, our study revealed that miR-34a plays a key role in ROS-induced MSC apoptosis. Repressing miR-34a expression by transfection of anti-34a increased MSC survival under oxidative stress. These findings offer a new insight into the importance of miR-34a in MSC apoptosis and suggest that manipulation of miR-34a expression may be a promising strategy to improve survival of transplanted MSCs in clinical stem cell therapies.

Supplementary materials
=======================

###### 

Immunostaining of Ki67 in MSCs after H~2~O~2~ treatment. After H~2~O~2~ treatment at different dosages (0, 50,100, 200, and 500 μM), Ki67 expression was detected by immunostaining. Left lane: DAPI; middle lane: Ki67; right lane: the merged image of DAPI and Ki67.
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![Increased miR-34a expression in MSCs under H~2~O~2~ stress. Cultured human bone marrow MSCs were challenged by 100 μM H~2~O~2~ for 1 h. miR-34a levels were measured by real-time PCR. There was an approximately 2-fold increase of miR-34a expression in MSCs after H~2~O~2~ exposure. Results were representative of 3 independent experiments. \*\*\* P\<0.001.](medscimonit-24-264-g001){#f1-medscimonit-24-264}

![Anti-34a effectively decreased miR-34a expression in MSCs. We transfected 200 nM anti-34a into human bone marrow MSCs for 24 h, and the expression level of miR-34a was measured by real-time PCR. \*\*\* P\<0.001.](medscimonit-24-264-g002){#f2-medscimonit-24-264}

![Anti-34a rescued H~2~O~2~ -induced cell death in MSCs. (**A**). miR-34a level was effectively suppressed by anti-34a under H~2~O~2~ stress. (**B**). H~2~O~2~ challenge significantly reduced the number of viable MSCs, and anti-34a partially rescued the effect of H~2~O~2~ challenge. \* P\<0.05; \*\* P\<0.01.](medscimonit-24-264-g003){#f3-medscimonit-24-264}

![Anti-34a protected MSCs against H~2~O~2~ by enhancing expression of Bcl-2, Survivin, and Ki67. (**A**). The mRNA levels of anti-apoptotic genes Bcl-2, Survivin, and proliferation marker Ki67 were significantly higher in MSCs transfected with anti-34a under H~2~O~2~ challenge. \* P\<0.05; \*\* P\<0.01; \*\*\* P\<0.001. (**B**). Consistent with mRNA expression, Bcl-2 and Survivin protein levels were partially rescued by anti-34a. \*\*\* P\<0.001.](medscimonit-24-264-g004){#f4-medscimonit-24-264}
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